Immediate Impact

36 standout
Sub-graph 1 of 13

Citing Papers

Preoperative assessment of adults undergoing elective noncardiac surgery
2024 Standout
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
2022 Standout
17 intermediate papers

Works of V. Roussel‐Robert being referenced

Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A
2014
Impact of Choice of Treatment for Bleeding Episodes on Inhibitor Outcome in Patients With Mild/Moderate Hemophilia A and Inhibitors
2006
and 2 more

Author Peers

Author Last Decade Papers Cites
V. Roussel‐Robert 294 69 44 45 18 326
Anwar Alhaq 197 168 43 41 19 341
James Uprichard 227 112 35 46 16 340
Sara L. Manning 100 45 48 58 21 273
Elisabetta Ruzzon 275 151 33 29 18 362
Engelfriet Cp 248 48 24 40 21 337
Jack Newman 203 50 56 22 17 324
David Diuguid 129 43 61 84 16 271
Z Currimbhoy 193 108 13 22 18 344
Guilherme Henrique Hencklain Fonsêca 183 216 21 13 17 299
Maria Socorro O Portella 336 110 17 39 11 362

All Works

Loading papers...

Rankless by CCL
2026